News Daily News Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI L.A. McKeown June 05, 2025
News Conference News ESC Heart Failure 2025 TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal Todd Neale May 21, 2025
News Conference News ESC Heart Failure 2025 Finerenone May Cut Early Readmissions in HF Patients Todd Neale May 21, 2025
News Conference News ESC Heart Failure 2025 No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI Todd Neale May 20, 2025
News Conference News ESC Heart Failure 2025 Cardiology Consults Tied to Better Outcomes in Patients With HF Todd Neale May 19, 2025
News Conference News ESC Heart Failure 2025 HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM Todd Neale May 19, 2025
News Daily News Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study Todd Neale May 09, 2025
News Daily News STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT Todd Neale May 08, 2025
News Conference News HRS 2025 VANISH2 Bolsters Data Backing VT Ablation in Ischemic Cardiomyopathy Todd Neale April 29, 2025
News Daily News Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM L.A. McKeown April 15, 2025
News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints L.A. McKeown April 03, 2025
News Conference News ACC 2025 Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP Michael O'Riordan April 01, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025
Presentation ACC 2025 Dapagliflozin after Transcatheter Aortic Valve Implantation Presenter: Sergio Raposeiras-Roubin March 29, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Daily News Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM Caitlin E. Cox March 21, 2025